Blue gradient background with vertical rounded lines in varying shades of blue scattered across the right side.Blue gradient background with vertical rounded lines in varying shades of blue scattered across the right side.
On-demand education
Filter
FILTER BY TESTS
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in uveal melanoma. Am J Ophthalmol 2018;195:154–60.

DecisionDx-UM
Authors: Cai L, Paez-Escamilla M, Walter SD, et al.
Prognostic
Ophthalmology

Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?

DecisionDx-UM
Authors: Binkley EM, Bena JF, Davanzo JM, Hinz C, Boldt HC, Singh AD
Prognostic
Ophthalmology

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009;457:599-602.

DecisionDx-UM
Authors: Van Raamsdonk CD, Bezrookove V, Green G, et al.
Prognostic
Ophthalmology

GNAQ and GNA11 mutations in uveal melanoma. Melanoma Res 2014;24:525-34.

DecisionDx-UM
Authors: Shoushtari AN and Carvajal RD.
Prognostic
Ophthalmology

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004;64:7205-9.

DecisionDx-UM
Authors: Onken MD, Worley LA, Ehlers JP, et al.
Prognostic
Ophthalmology

Genomic research in uveal melanoma. Retina Today 2010:67-9.

DecisionDx-UM
Authors: Harbour JW
Prognostic
Ophthalmology

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 2011;48:856-9.

DecisionDx-UM
Authors: Abdel-Rahman MH, Pilarski R, Cebulla CM, et al.
Prognostic
Ophthalmology

Gene expression profiling in uveal melanoma: five-year prospective outcomes and meta-analysis.

DecisionDx-UM
Authors: Aaberg TM, Covington KR, Tsai T, et al
Prognostic
Ophthalmology

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One 2012;7: e35295.

DecisionDx-UM
Authors: Njauw CN, Kim I, Piris A, et al.
Prognostic
Ophthalmology

Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes. JAMA Ophthalmol 2016;134(7):728-33.

DecisionDx-UM
Authors: Decatur CL, Ong, E, Garg, N, et al.
Prognostic
Ophthalmology

Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases. Clin Genet 2016;89:285-94.

DecisionDx-UM
Authors: Rai K, Pilarski R, Cebulla CM, et al.
Prognostic
Ophthalmology

Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet 2013;45:933-6.

DecisionDx-UM
Authors: Martin M, Masshofer L, Temming P, et al.
Prognostic
Ophthalmology